文献速递青光眼

三级医疗中心青光眼引流管手术的10年临床结局

10-Year Clinical Outcomes of Tube Shunt Surgery at a Tertiary Care Center.
PubMed 文献 · Am J Ophthalmol · 2023-04-16

回顾性队列研究纳入2005年1月至2011年12月在一家三级转诊眼科医院接受首次青光眼引流管手术且随访至少10年的患眼,报告10年临床结局。末次随访时平均眼压从29.2±10.4 mmHg(使用3.1±1.2种药物)降至12.6±5.8 mmHg(使用2.2±1.4种药物),但56%的患眼符合失败标准,34%接受了额外青光眼手术,结局不因引流管型号而异。

要点

  • 末次随访平均眼压从29.2±10.4 mmHg降至12.6±5.8 mmHg,用药从3.1±1.2种降至2.2±1.4种(各p<0.001)。
  • 56%患眼符合失败标准,34%接受额外青光眼手术,10%进展至无光感。
  • 最佳矫正视力logMAR从0.8±0.7(20/125)恶化至1.4±1.0(20/500)(p<0.001)。

核心结论

  • 许多患眼在青光眼引流管手术后10年维持眼压控制,但56%符合失败标准、39%有显著视力丧失、34%接受额外手术。
  • 结局不因青光眼引流管型号而异。

研究设计与样本

  • 回顾性队列研究,纳入2005年1月至2011年12月在一家三级转诊眼科医院接受首次青光眼引流管手术且随访至少10年的患眼。
  • 研究组85眼(78例患者),对照组89眼;平均随访11.9±1.7年。
  • 失败定义为:为降低眼压再次手术、连续两次随访眼压>基线值的80%、或进展至无光感。

主要发现

  • 置入带阀引流管51眼(60%)、非带阀25眼(29%)、型号不明9眼(11%)。
  • 末次随访平均眼压从29.2±10.4 mmHg(使用3.1±1.2种药物)降至12.6±5.8 mmHg(使用2.2±1.4种药物),各p<0.001。
  • 48眼(56%)失败;29眼(34%)接受额外青光眼手术;8眼(10%)进展至无光感;34眼(40%)还需引流管翻修。
  • 最佳矫正视力logMAR从0.8±0.7(20/125)恶化至1.4±1.0(20/500)(p<0.001)。
  • 平均视野MD基线为-13.9±7.5 dB,末次随访为-17.0±7.0 dB(P=0.0605)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report 10-year clinical outcomes of tube shunt (TS) surgery at a tertiary care center. DESIGN: Retrospective cohort study. METHODS: Eyes were included that underwent a first TS surgery between January 2005 and December 2011 at a tertiary referral eye hospital and with at least 10 years of follow-up. Demographic and clinical data were collected. Failure was defined as reoperation to lower intraocular pressure (IOP), IOP > 80% of baseline for two consecutive visits, or progression to no light perception. RESULTS: Eighty-five eyes of 78 patients were included in the Study Group; 89 eyes were selected as a Comparison Group. Mean follow-up was 11.9 ± 1.7 years. Fifty-one valved (60%), 25 non-valved (29%), and nine unknown (11%) TS were placed. At the final visit, mean IOP was reduced from 29.2 ± 10.4 mmHg on 3.1 ± 1.2 medications to 12.6 ± 5.8 mmHg on 2.2 ± 1.4 (p<0.001 for each). Forty-eight eyes (56%) failed; 29 eyes (34%) underwent additional glaucoma surgery; eight eyes (10%) progressed to no light perception; and 34 eyes (40%) also required TS revision. Best corrected visual acuity (BCVA) logMAR (minimal angle of resolution) worsened from 0.8 ± 0.7 (20/125) to 1.4 ± 1.0 (20/500) at the last visit (p<0.001). Average visual field MD was -13.9 ± 7.5 dB at baseline and -17.0 ± 7.0 dB at last follow-up (P=0.0605). CONCLUSIONS: Many eyes maintained IOP control 10 years following TS, but 56% met failure criteria, 39% had substantial vision loss, and 34% underwent additional surgery. Outcomes did not differ with TS model. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Myers JS, Lamrani R, Hallaj S, et al. 10-Year Clinical Outcomes of Tube Shunt Surgery at a Tertiary Care Center. Am J Ophthalmol. 2023. PMID: 37072075. doi:10.1016/j.ajo.2023.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。